ÂÜÀòÂÒÂ×

Alok Das Mohapatra, Ph.D., currently serves as Principal Scientist in Pre Clinical-In Vivo Pharmacology at TScan Therapeutics, focusing on the development of preclinical xenograft models for various solid and liquid tumors, and the execution of studies involving engineered TCR-T cells. Prior roles include Senior Scientist at Flagship Pioneering, where Alok led preclinical discovery projects in cell therapy, and Senior Research Associate at the University of Massachusetts Medical School, investigating EBV pathogenesis in B-cell Lymphoma. Alok's postdoctoral experience includes significant research at Brown University and UConn Health, emphasizing tumor immunology and dendritic cell-based therapies. Alok earned a PhD in Life Sciences with a specialization in Cellular Immunology from the Institute of Life Sciences and holds a Master’s degree in Microbiology from Orissa University of Agriculture and Technology.